Ertapenem Injection, Powder, Lyophilized, For Solution
Product Images NDC 42023-221
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ertapenem (NDC 42023-221). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Endo Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Principal Display Panel (1 g Vial Tray Label)
This is a drug product. It comes in the form of 10 single-dose vials, each containing 1 gram of Ertapenem Sodium for intravenous or intramuscular use. It is formulated in France and manufactured for Par Pharmaceutical in Chestnut Ridge, NY. Inactive ingredients include sodium bicarbonate and sodium hydroride to adjust the pH. The solutions range from colorless to pale yellow. The expiration date and lot number are also provided, but instructions for reconstitution, dilution, and usual dosage are not. The packaging includes a warning to discard any unused portion and to not store the lyophilized powder above 25°C.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.